| Roopa Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530991 |
NSE Symbol : - |
P/E(TTM) : 8.76 |
|
ISIN Demat : INE443C01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.36 |
|
Book Value(₹) : 22.37 |
Market Cap(₹Cr) : 36.94 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 33.32 | 30.14 | 33.54 | 28.74 | 35.07 | 29.83 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 33.32 | 30.14 | 33.54 | 28.74 | 35.07 | 29.83 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.11 | 0.00 | 0.00 | 0.02 | 1.14 |
| Total Income | 33.35 | 30.25 | 33.54 | 28.75 | 35.09 | 30.97 |
| Total Expenditure | 31.80 | 31.16 | 31.51 | 27.11 | 33.67 | 29.39 |
| PBIDT | 1.55 | -0.91 | 2.03 | 1.64 | 1.43 | 1.58 |
| Interest | 0.93 | 0.74 | 0.79 | 0.83 | 0.86 | 0.66 |
| PBDT | 0.62 | -1.65 | 1.25 | 0.80 | 0.56 | 0.92 |
| Depreciation | 0.19 | 0.21 | 0.19 | 0.19 | 0.20 | 0.19 |
| Tax | 0.11 | -0.42 | 0.27 | 0.16 | 0.10 | 0.23 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.01 | 0.01 | -0.01 | -0.01 | 0.09 |
| Reported Profit After Tax | 0.33 | -1.43 | 0.77 | 0.46 | 0.28 | 0.42 |
| Extra-ordinary Items | 0.00 | -4.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.33 | 2.66 | 0.77 | 0.46 | 0.28 | 0.42 |
| EPS (Unit Curr.) | 0.43 | -1.80 | 0.98 | 0.59 | 0.36 | 0.51 |
| EPS (Adj) (Unit Curr.) | 0.43 | -1.80 | 0.98 | 0.59 | 0.36 | 0.51 |
| Calculated EPS (Unit Curr.) | 0.42 | -1.82 | 0.98 | 0.59 | 0.36 | 0.53 |
| Calculated EPS (Adj) (Unit Curr.) | 0.42 | -1.82 | 0.98 | 0.59 | 0.36 | 0.53 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.67 | -7.29 | 3.91 | 2.36 | 1.44 | 2.13 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.67 | -7.29 | 3.91 | 2.36 | 1.44 | 2.13 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 4.65 | -3.02 | 6.05 | 5.71 | 4.08 | 5.30 |
| PBDTM(%) | 1.86 | -5.47 | 3.73 | 2.78 | 1.60 | 3.08 |
| PATM(%) | 0.99 | -4.74 | 2.30 | 1.60 | 0.80 | 1.41 |
